Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $5.1 million.

  • Immunocore Holdings' Non Operating Income fell 4351.71% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year increase of 2461.2%. This contributed to the annual value of $14.2 million for FY2024, which is 168283.17% up from last year.
  • As of Q3 2025, Immunocore Holdings' Non Operating Income stood at $5.1 million, which was down 4351.71% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Non Operating Income registered a high of $9.0 million during Q3 2024, and its lowest value of -$1.8 million during Q4 2021.
  • In the last 5 years, Immunocore Holdings' Non Operating Income had a median value of -$190000.0 in 2023 and averaged $1.7 million.
  • In the last 5 years, Immunocore Holdings' Non Operating Income crashed by 10751.67% in 2023 and then soared by 476770.83% in 2024.
  • Quarter analysis of 5 years shows Immunocore Holdings' Non Operating Income stood at -$1.8 million in 2021, then soared by 240.15% to $2.5 million in 2022, then crashed by 107.52% to -$191000.0 in 2023, then skyrocketed by 619.9% to $993000.0 in 2024, then soared by 409.77% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $4.7 million for Q2 2025, and $5.5 million during Q1 2025.